Going All In for Ocrevus — Together

“Is the MS drug news good for u?” my friend’s text asked. It was Wednesday morning, March 29. Genentech had just announced  that Ocrevus, the “First and only approved disease-modifying therapy for primary progressive form of multiple sclerosis (PPMS) – one of the most disabling forms of multiple sclerosis,” had been approved by the U.S. Food and Drug Administration (FDA). It is given by intravenous infusion.

My friend and her family are among my biggest advocates and supporters, and in their way, cheerleaders. “The shortest answer is maybe,” I wrote back. “But maybe is a far better answer than no.”

Early the next morning my neurologist called. My wife was running late and I was trying to help her fly out the door. One of our cats was in a pet carrier, howling as she waited for me to take her to the vet. I was in the eye of the tornado and it wasn’t the best time to talk. But his call was unexpected and it was my neurologist. 

“Did you hear the news about Ocrevus?” he asked. By then I had watched the drug’s long progression from potential breakthrough to its approval for use here in the U.S. For the past year I’d pestered my neurologist to determine if I would be a candidate for the treatment and we had talked about it several times. His call shouldn’t have surprised me. “You were at the top of my list to call to see if you wanted to set up an appointment to come in and talk about the pros and cons of the medicine.”

Two days later the lawyer handling my Social Security disability application called and left a message asking if I’d heard about “a miracle drug’s approval for treating multiple sclerosis.”

My journey with MS began in 2001. I was 41 years old then and training for what I had hoped to be the first of several marathons. Ever so gradually I developed a gait problem that ever-so-gradually made it impossible to run. Today, I need a cane to walk and am shopping for a walker. I wrote this column using voice-to-text technology because motor loss in my right hand has rendered it useless for typing.

Progression is unpredictable

There were plenty of warning signs and seemingly disparate illnesses over the ensuing years, but I wasn’t diagnosed until Dec. 27, 2013 when connecting what were, in retrospect, classic MS symptoms became impossible to ignore. Though I had very few episodes that might be considered exacerbations or flare-ups, in the spring of 2014 I received medication meant for patients with relapsing MS. Months later I spoke with my neurologist again, complaining that nothing was changing. “It may take a while before you notice the effects,” he said.

But I continued to worsen. Today, my neurologist and I have come to agree that mine is a progressive form of MS. It just went unrecognized for so long that the marked debilitation I’ve experienced over the past three years seems comparatively sudden.

I understand now that MS is different for everyone, that its arc and and progression are unpredictable and the only thing that is predictable is the disease’s chaotic nature. So, I’ve learned not to be enthusiastic, but have become cautious and guarded about everything associated with MS, taking everything with many grains of salt. Truckloads of salt.

Nearly everything MS is doing with me is out of my control, except for trying to take care of myself, which isn’t. I attend a weekly Pilates session with an instructor trained to work with MS clients. Though it’s very awkward, I continue to ride my bicycle and work out several times a week. We get together with friends and go out as frequently as we can, even when I don’t feel like it. Sometimes when I don’t want to do those things, I think of them as an obligation to those who are supporting me, who were enthusiastic and inquired excitedly if I’d heard the news, and who asked if Ocrevus is going to help me. Because they need to know I am not giving up.

They’ve lived this disease with me and and the news about Ocrevus has left them enthusiastic. They need to be enthusiastic in order to keep slogging this out. Yet, I am skeptical about Ocrevus because of my history with MS and because there’s much left to learn about the drug. I also am afraid of the massive letdown we may all experience if it doesn’t work. 

For everyone’s sake, I am trying to be enthusiastic and have faith that they’ll be there for me even if Ocrevus doesn’t change anything for me. I’m scheduled to meet with my neurologist within the week. If we’re going to do this, I know we’re going all in and I know were going all in together.

***

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.